VisionPoint Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.11M Buy
4,262
+2,175
+104% +$2.22M 0.83% 24
2026
Q1
$1.92M Buy
2,087
+220
+12% +$223K 0.36% 67
2025
Q4
$2.01M Buy
1,867
+309
+20% +$295K 0.39% 70
2025
Q3
$1.19M Sell
1,558
-423
-21% -$315K 0.24% 106
2025
Q2
$1.54M Buy
1,981
+939
+90% +$730K 0.34% 85
2025
Q1
$861K Sell
1,042
-16
-2% -$13.3K 0.3% 75
2024
Q4
$823K Sell
1,058
-284
-21% -$235K 0.28% 91
2024
Q3
$1.19M Buy
1,342
+117
+10% +$105K 0.4% 74
2024
Q2
$1.11M Buy
1,225
+5
+0.4% +$4K 0.39% 68
2024
Q1
$949K Buy
1,220
+619
+103% +$441K 0.34% 80
2023
Q4
$350K Sell
601
-1
-0.2% -$584 0.13% 119
2023
Q3
$323K Sell
602
-89
-13% -$45.9K 0.14% 118
2023
Q2
$324K Sell
691
-42
-6% -$17.6K 0.13% 111
2023
Q1
$314K Sell
733
-120
-14% -$40.5K 0.14% 114
2022
Q4
$299K Sell
853
-215
-20% -$76.2K 0.12% 102
2022
Q3
$345K Buy
1,068
+79
+8% +$25K 0.17% 64
2022
Q2
$298K Buy
+989
New +$297K 0.12% 82

Other funds holding LLY

VisionPoint Advisory Group's LLY Position: Q2 2026 in Review

VisionPoint Advisory Group increased its Eli Lilly (LLY) stake by 104% in Q2 2026, buying an estimated $2.22M and bringing the position to 4,262 shares worth $5.11M. The position accounts for 0.83% of the portfolio, ranked #24.

VisionPoint Advisory Group first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • VisionPoint Advisory Group held 4,262 shares of Eli Lilly worth $5.11M as of Q2 2026.
  • VisionPoint Advisory Group bought 2,175 Eli Lilly shares in Q2 2026, an estimated $2.22M.
  • Eli Lilly made up 0.83% of VisionPoint Advisory Group's portfolio in Q2 2026, its #24 holding.
  • VisionPoint Advisory Group first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.